HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose related sequence of effects induced by the DA agonist 2-(N,N-dipropyl)-amino-5,6-dihydroxytetralin.

Abstract
2-N,N-dipropylamino 5,6-dihydroxytetralin (nPr2 ADTN), a potent dopaminergic agonist, induces the same polyphasic effects observed with apomorphine by Protais et al., (1983). The dose related sequence of behaviours in mice can be summed up as followed: to 0.9 to 3.9 micrograms.kg-1, a decrease in motor activity without any other effects; to 7.8 to 15.6 micrograms.kg-1, a return to control level or an increase in motility alone according to experimental conditions; to 31 to 62.5 micrograms.kg-1, a second phase of hypomotility when hypothermia develops; above 125 micrograms.kg-1, a second phase of hypermotility when both stereotypies and climbing behaviour appear. Hypothermia moreover, disappears. The effects of the nPr2 ADTN were compared with those of apomorphine obtained in others studies (Puech et al., 1974; Protais et al., 1983). The tetralin derivative differs from apomorphine in that the first phase of hypermotility it induces is greater, and that hypothermia disappears at high doses.
AuthorsL Doaré, A J Puech, P Simon
JournalJournal de pharmacologie (J Pharmacol) 1986 Jan-Mar Vol. 17 Issue 1 Pg. 60-4 ISSN: 0021-793X [Print] France
PMID3713199 (Publication Type: Journal Article)
Chemical References
  • Naphthalenes
  • Receptors, Dopamine
  • Tetrahydronaphthalenes
  • 2-(N,N-dipropyl)amino-5,6-dihydroxytetralin
  • Adenylyl Cyclases
  • Apomorphine
Topics
  • Adenylyl Cyclases (metabolism)
  • Animals
  • Apomorphine (pharmacology)
  • Body Temperature (drug effects)
  • Dose-Response Relationship, Drug
  • Male
  • Mice
  • Motor Activity (drug effects)
  • Naphthalenes (pharmacology)
  • Receptors, Dopamine (drug effects)
  • Stereotyped Behavior (drug effects)
  • Tetrahydronaphthalenes (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: